Fierce Pharma
NOVEMBER 3, 2023
Pfizer’s plunging COVID-19 product demand has spurred a companywide cost-cutting campaign, with nearly 200 jobs now on the chopping block in Michigan. | Pfizer is cutting roughly 200 positions at its Kalamazoo site following a review of demand for its COVID-19 vaccine and antiviral Comirnaty and Paxlovid.
MedCity News
NOVEMBER 3, 2023
Changes in HHS structure, along with well-funded and staffed partners at the state, local, tribal and territorial levels, may prove helpful for success during future public health emergencies and can help earn and maintain the public’s trust.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 3, 2023
Bausch Health’s gastroenterology unit Salix Pharmaceuticals has chalked up a win in its long-running fight to fend off a generic to its irritable bowel syndrome diarrhea (IBD-D) med Xifaxan. | The D.C. federal court denied Alvogen's bid to force the FDA to grant full approval to its proposed Xifaxan generic. The agency previously gave the generic a tentative approval before some patents expire in 2029.
MedCity News
NOVEMBER 3, 2023
A new Duke study shows that KelaHealth’s platform was associated with a 21% reduction in acute kidney injury and a 24% decrease in costly readmissions following colorectal surgery. The platform delivers insights about individual patients’ surgical risks and what their care journeys should look like.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
NOVEMBER 3, 2023
Olivia Gannon, Associate Director of Global MES and Digital Execution Systems, Life Sciences Manufacturing, Cognizant, explores how a digitalization strategy harnessing the latest innovatio | Olivia Gannon, Global MES Service Line Lead at Cognizant, explores how a digitalization strategy harnessing the latest innovations in MES technologies can help streamline life science manufacturing.
European Pharmaceutical Review
NOVEMBER 3, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Litfulo’s active ingredient, ritlecitinib, is an enzyme inhibitor. It works irreversibly and selectively inhibits Janus kinase 3 (JAK3) and the tyrosine (TEC) family of kinases by blocking γ-common cytokine signalling and reduc
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 3, 2023
This article delves into the importance of audience segmentation, offers guidance on identifying distinct audience groups, and discusses influential personas in healthcare.
PharmaTech
NOVEMBER 3, 2023
Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
MedCity News
NOVEMBER 3, 2023
The gene therapy programs of Lexeo Therapeutics span rare forms of cardiomyopathy and certain types of Alzheimer’s disease. But Lexeo’s IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets.
PharmExec
NOVEMBER 3, 2023
Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
NOVEMBER 3, 2023
Amid the unwinding of the continuous enrollment provision, more than 10 million people have lost Medicaid coverage, according to data from KFF. Of those disenrolled from Medicaid coverage, 71% were removed from coverage for procedural reasons.
PharmaTimes
NOVEMBER 3, 2023
Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented - News - PharmaTimes
Copyright Clearance Center
NOVEMBER 3, 2023
KDP authors can now choose from a selection of AI-generated narrators to create a machine-generated audiobook.
PharmaTimes
NOVEMBER 3, 2023
Over 63,000 cancer cases were diagnosed between one and five years after referral - News - PharmaTimes
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmExec
NOVEMBER 3, 2023
The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines.
pharmaphorum
NOVEMBER 3, 2023
Study finds higher cancer rate in patients given ‘all clear’ Phil.
PharmaTech
NOVEMBER 3, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.
PharmExec
NOVEMBER 3, 2023
Ongoing phase 1 dose-escalation trial of KO-2806 (FIT-001) for the treatment of patients with KRASG12C-mutated non-small cell lung cancer expected to begin dosing patients in combination with adagrasib by mid-2024.
Referral MD
NOVEMBER 3, 2023
How the Healthcare Digital Front Door Improves Office Efficiency In recent years, the healthcare industry has undergone a transformation driven by digital technologies. One significant aspect of this transformation is implementing a healthcare digital front door. The digital front door refers to the virtual entry point that connects patients with healthcare providers, allowing them to access services and communicate with their healthcare team online.
Legacy MEDSearch
NOVEMBER 3, 2023
POLARIS AR is pleased to announce today that their STELLAR Knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). STELLAR Knee is the first clearance for POLARIS AR , a company focused on creating a new category in Mixed Reality surgical guidance. POLARIS AR and STELLAR Knee are building the intersection of physical surgery and virtual surgical guidance, bringing about a one-of-a-kind digital operating room environment.
PharmaTech
NOVEMBER 3, 2023
Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, highlights one approach to ensuring the continuation of analytical expertise.
Pharmaceutical Technology
NOVEMBER 3, 2023
The large amendment to Poland’s Reimbursement Act (Duża Nowelizacja Ustawy Refundacyjnej, DNUR) finally came into legal force on November 1, although a small number of its regulations will only come into force in 2024 and 2025.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
NOVEMBER 3, 2023
Pharmaceutical Technology Europe® spoke with Leonardo Vincenzi from CONTINUUS Pharmaceuticals, a US company that specializes in process development, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
pharmaphorum
NOVEMBER 3, 2023
Moderna swings to loss as COVID sales slump Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
Driven by success of recent GLP1R-targeting drugs, there has been a surge in the number of active pipeline drugs addressing this target for type 2 diabetes.
Pharmaceutical Commerce
NOVEMBER 3, 2023
With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.
pharmaphorum
NOVEMBER 3, 2023
Lexeo files $100m IPO in tough listing environment Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
In May 2022, Terremoto raised $75m on Series A financing for its lysine-based covalency drug development platform.
PharmaVoice
NOVEMBER 3, 2023
From biotech startups to a services agency, these entrepreneurs are hedging their bets to offer innovative approaches in patient care.
Pharmaceutical Technology
NOVEMBER 3, 2023
The European Commission (EC) has approved Gedeon Richter and Sumitomo Pharma’s Type II Variation application for RYEQO for endometriosis.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
354 
Let's personalize your content